311 related articles for article (PubMed ID: 23491023)
1. Clinical outcomes of high-dose-rate interstitial gynecologic brachytherapy using real-time CT guidance.
Lee LJ; Damato AL; Viswanathan AN
Brachytherapy; 2013; 12(4):303-10. PubMed ID: 23491023
[TBL] [Abstract][Full Text] [Related]
2. Predictors of toxicity after image-guided high-dose-rate interstitial brachytherapy for gynecologic cancer.
Lee LJ; Viswanathan AN
Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1192-7. PubMed ID: 22592049
[TBL] [Abstract][Full Text] [Related]
3. Image and laparoscopic guided interstitial brachytherapy for locally advanced primary or recurrent gynaecological cancer using the adaptive GEC ESTRO target concept.
Fokdal L; Tanderup K; Nielsen SK; Christensen HK; Røhl L; Pedersen EM; Schønemann NK; Lindegaard JC
Radiother Oncol; 2011 Sep; 100(3):473-9. PubMed ID: 21924784
[TBL] [Abstract][Full Text] [Related]
4. Inverse-planned gynecologic high-dose-rate interstitial brachytherapy: clinical outcomes and dose--volume histogram analysis.
Thibault I; Lavallée MC; Aubin S; Laflamme N; Vigneault E
Brachytherapy; 2012; 11(3):181-91. PubMed ID: 21862418
[TBL] [Abstract][Full Text] [Related]
5. A prospective trial of real-time magnetic resonance-guided catheter placement in interstitial gynecologic brachytherapy.
Viswanathan AN; Szymonifka J; Tempany-Afdhal CM; O'Farrell DA; Cormack RA
Brachytherapy; 2013; 12(3):240-7. PubMed ID: 23415048
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes following 3D image-guided brachytherapy for vaginal recurrence of endometrial cancer.
Lee LJ; Damato AL; Viswanathan AN
Gynecol Oncol; 2013 Dec; 131(3):586-92. PubMed ID: 24029418
[TBL] [Abstract][Full Text] [Related]
7. High-dose-rate interstitial brachytherapy for gynecologic malignancies.
Beriwal S; Bhatnagar A; Heron DE; Selvaraj R; Mogus R; Kim H; Gerszten K; Kelley J; Edwards RP
Brachytherapy; 2006; 5(4):218-22. PubMed ID: 17118313
[TBL] [Abstract][Full Text] [Related]
8. CT-based interstitial brachytherapy in advanced gynecologic malignancies: outcomes from a single institution experience.
D'Souza D; Wiebe E; Patil N; Sugimoto A; Prefontaine M; Aulakh S; Whiston F; Stitt L; Surry K
Brachytherapy; 2014; 13(3):225-32. PubMed ID: 24613570
[TBL] [Abstract][Full Text] [Related]
9. Dosimetric impact of interfraction catheter movement and organ motion on MRI/CT guided HDR interstitial brachytherapy for gynecologic cancer.
Rey F; Chang C; Mesina C; Dixit N; Kevin Teo BK; Lin LL
Radiother Oncol; 2013 Apr; 107(1):112-6. PubMed ID: 23333023
[TBL] [Abstract][Full Text] [Related]
10. Predictors of severe gastrointestinal toxicity after external beam radiotherapy and interstitial brachytherapy for advanced or recurrent gynecologic malignancies.
Kasibhatla M; Clough RW; Montana GS; Oleson JR; Light K; Steffey BA; Jones EL
Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):398-403. PubMed ID: 16542793
[TBL] [Abstract][Full Text] [Related]
11. High-dose-rate interstitial computed tomography-based brachytherapy for the treatment of cervical cancer: early results.
Kannan N; Beriwal S; Kim H; Houser C; Mogus R; Sukumvanich P; Olawaiye AB; Richard S; Kelley JL; Edwards RP; Krivak TC
Brachytherapy; 2012; 11(5):408-12. PubMed ID: 22513106
[TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance-guided interstitial therapy for vaginal recurrence of endometrial cancer.
Viswanathan AN; Cormack R; Holloway CL; Tanaka C; O'Farrell D; Devlin PM; Tempany C
Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):91-9. PubMed ID: 16839709
[TBL] [Abstract][Full Text] [Related]
13. Image-guided vulvovaginal interstitial brachytherapy in the treatment of primary and recurrent gynecological malignancies.
De Ieso PB; Mullassery V; Shrimali R; Lowe G; Bryant L; Hoskin PJ
Brachytherapy; 2012; 11(4):306-10. PubMed ID: 21996537
[TBL] [Abstract][Full Text] [Related]
14. Three-dimensional image-based high-dose-rate interstitial brachytherapy for vaginal cancer.
Beriwal S; Rwigema JC; Higgins E; Kim H; Houser C; Sukumvanich P; Olawaiye A; Richard S; Kelley JL; Edwards RP; Krivak TC
Brachytherapy; 2012; 11(3):176-80. PubMed ID: 21665553
[TBL] [Abstract][Full Text] [Related]
15. Permanent interstitial reirradiation with 198Au as salvage therapy for low volume recurrent gynecologic malignancies: a single institution experience.
Brabham JG; Cardenes HR
Am J Clin Oncol; 2009 Aug; 32(4):417-22. PubMed ID: 19451799
[TBL] [Abstract][Full Text] [Related]
16. Early clinical outcomes of ultrasound-guided CT-planned high-dose-rate interstitial brachytherapy for primary locally advanced cervical cancer.
Mesko S; Swamy U; Park SJ; Borja L; Wang J; Demanes DJ; Kamrava M
Brachytherapy; 2015; 14(5):626-32. PubMed ID: 26024784
[TBL] [Abstract][Full Text] [Related]
17. Clinical comparison of two linear-quadratic model-based isoeffect fractionation schemes of high-dose-rate intracavitary brachytherapy for cervical cancer.
Wang CJ; Huang EY; Sun LM; Chen HC; Fang FM; Hsu HC; Changchien CC; Leung SW
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):179-89. PubMed ID: 15093915
[TBL] [Abstract][Full Text] [Related]
18. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer.
Alektiar KM; Venkatraman E; Chi DS; Barakat RR
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):111-7. PubMed ID: 15850910
[TBL] [Abstract][Full Text] [Related]
19. Computed tomography-planned interstitial brachytherapy for locally advanced gynecologic cancer: Outcomes and dosimetric predictors of urinary toxicity.
Amsbaugh MJ; Bhatt N; Hunter T; Gaskins J; Parker L; Metzinger D; Amsbaugh A; Sowards K; El-Ghamry MN
Brachytherapy; 2016; 15(1):49-56. PubMed ID: 26614237
[TBL] [Abstract][Full Text] [Related]
20. Prospective multi-institutional study of definitive radiotherapy with high-dose-rate intracavitary brachytherapy in patients with nonbulky (<4-cm) stage I and II uterine cervical cancer (JAROG0401/JROSG04-2).
Toita T; Kato S; Niibe Y; Ohno T; Kazumoto T; Kodaira T; Kataoka M; Shikama N; Kenjo M; Tokumaru S; Yamauchi C; Suzuki O; Sakurai H; Numasaki H; Teshima T; Oguchi M; Kagami Y; Nakano T; Hiraoka M; Mitsuhashi N
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):e49-56. PubMed ID: 21470794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
